Quotient Therapeutics
Signal active
Organization
Contact Information
Overview
Quotient Therapeutics engages in transformative medicines made possible with somatic genomics.
About
Industries
Biotechnology, Life Science, Medical
Founded
2022
Employees
0
Headquarters locations
Europe
Social
N/A
Profile Resume
Quotient Therapeutics headquartered in Europe, operates in the Biotechnology, Life Science, Medical sector. The company focuses on Biotechnology and has secured $600.0M in funding across 12 round(s). Their latest funding round, Seed Round - Quotient Therapeutics, raised $50.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
1
Lead Investors
0
Total Funding Amount
$50.0M
Details
1
Quotient Therapeutics has raised a total of $50.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed | 50.0M |
Investors
Quotient Therapeutics is funded by 5 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Geoffrey von Maltzahn | - | FUNDING ROUND - Geoffrey von Maltzahn | 50.0M |
| Noubar Afeyan | - | FUNDING ROUND - Noubar Afeyan | 50.0M |
| Quotient Therapeutics | - | FUNDING ROUND - Quotient Therapeutics | 50.0M |
| Flagship Pioneering | - | FUNDING ROUND - Flagship Pioneering | 50.0M |
Recent Activity
There is no recent news or activity for this profile.